The following criteria must be met to be eligible for the ADVANCE program:
The Principal Investigator holds a doctoral degree (MD, PhD, PharmD, or equivalent). Proposals should have one Principal Investigator but can include multiple co-investigators.
Investigators must be affiliated with an academic or medical institution.
Research must be conducted in accordance with local regulatory, legal, and ethical guidelines, including posting on a clinical trial registry where appropriate. Pfizer Inc./Eli Lilly and Company assume no responsibility for the conduct of the selected studies.
The Principal Investigator is not receiving or will not receive funding from other pharmaceutical companies for the submitted research proposal.
Proposals must be submitted in English.
The maximum amount of funding requested for your project is no more than US $200,000.
Budgets must be submitted in US $. Total budget includes direct costs (eg, labor and study costs), administrative costs to the institution associated with the conduct of the research funded by the grant, and any other costs (eg, additional expenses such as software fees and travel costs).
Additional Submission Criteria
The study must start within 6 months of contract execution and the duration of study treatment and follow-up should not exceed 2 years.
All funded research should merit submission as an abstract to scientific meetings and a subsequent full manuscript publication in a peer-reviewed journal.
All above criteria must be met for valid submission to the ADVANCE program. Proposals not meeting all eligibility criteria will not be forwarded to the Independent Review Committee for review.